Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00005589 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: carmustine
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
PROCEDURE: bone marrow ablation with stem cell support
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

EBMT Solid Tumors Working Party

Collaborators

[object Object]